Autism Spectrum Disorder (ASD) is classified as a developmental disorder characterized by impairment in communication, behavior, and social interaction. Diagnosis has improved in the U.S., with ASD prevalence estimated at 1 in 54 children. In Nigeria, reliable data remain limited, with estimates ranging from 0.8% to 2.9%. However, the true prevalence is likely higher due to underdiagnosis.
Significant differences exist between autism care in the U.S. and Nigeria. In the U.S., telemedicine, mobile health applications, and online support platforms have transformed care delivery, especially during COVID-19 when telemedicine use for autism increased by 88%. These tools reduce barriers, support continuous monitoring, and improve patient–provider communication.
Nigeria faces far greater challenges. Infrastructure limitations, lack of specialists, and socioeconomic inequality reduce access to services. Cultural stigma further discourages families from pursuing early intervention. Less than 40% of Nigerians have reliable internet access, and high mobile data costs hinder digital adoption. Still, there is strong potential for Nigeria to localize U.S. technological innovations.